Asterand Logo Home Glossary Contact Us Online Ordering




XpressWayTM Profiles
CustomMappingTM
In situ Hybridization
Immunohistochemistry
Autoradiography
Core Capabilities

Core Capabilities

GryDiv

Asterand offers extensive scientific expertise in human tissue research. Since 1996, we have conducted human tissue based in vitro studies for pharmaceutical companies to aid their selection of drug candidates with an increased likelihood of success. Through our PhaseZERO® platform we offer a range of standard and custom assays in IHC, ISH, cell and tissue-based pharmacology. Asterand's worldwide procurement network facilitates timely access human tissue and biofluid samples from a broad range of diseases that are suitable for conducting these experiments. In addition, we offer human cell lines and primary cells specifically for in vitro studies.

The following is the list of our standard assays based on disease state, therapeutic focus and research area. Custom assays can be developed upon request:

1. Metabolic

2. Respiratory

3. Inflammation

4. Genitourinary

5. Cardiovascular

6. CNS

7. Gastrointestinal

8. Oncology

9. Safety Pharmacology

10. Secondary Pharmacology

11. Toxicology

12. Assays suitable for all therapeutic areas

Please send an e-mail to advantage@asterand.com for further information.

Benefits of working with Asterand

Our human tissue-based approach allows rapid and early evaluation of targets and biomarkers in biologically relevant tissues to:

  • accelerate development
  • reduce the risk of late stage failures
  • improve productivity

We offer:

  • Extensive experience in human tissue research and drug discovery
  • High quality human tissues and comprehensive clinical data
  • All human biomaterials are sourced with stringent ethical standards and consent for research
  • A fee for service price structure - all resulting data and IP belong to our customers
  • A single outsource solution for your human tissue needs


© 2008 Asterand plc. All rights reserved Terms of Use  GryDiv   E-Newsletter